These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1555722)

  • 1. [The effect of the new metabolic preparations rikavit and mildronat on the parameters of the blood acid-base balance in humans with hypoxia].
    Serebrovs'ka ZA; Denisenko HT; Serebrovs'ka TV
    Fiziol Zh (1978); 1992; 38(1):26-31. PubMed ID: 1555722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The characteristics of the action of mildronate (dihydrate 3-(2,2,2-trimethylhydrazine)propionate) on the red blood parameters in heart failure].
    Sisetskiĭ AP; Artiukh VP; Sakharchuk II; Starodub NF
    Eksp Klin Farmakol; 1992; 55(3):20-1. PubMed ID: 1458154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The use of mildronate and trental in treating disorders of hemorheology and the intracardiac hemodynamics in patients with chronic obstructive bronchitis].
    Sakharchuk II; Il'nyts'kyĭ RI
    Lik Sprava; 1996; (1-2):122-5. PubMed ID: 9005070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The use of mildronate in combined therapy of postinfarction chronic heart failure in patients with type 2 diabetes mellitus].
    Statsenko ME; Belenkova SV; Sporova OE; Shilina NN
    Klin Med (Mosk); 2007; 85(7):39-42. PubMed ID: 17882808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mildronate: an antiischemic drug for neurological indications.
    Sjakste N; Gutcaits A; Kalvinsh I
    CNS Drug Rev; 2005; 11(2):151-68. PubMed ID: 16007237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The use of mildronat with stenocardia patients].
    Dudko VA; Koshel'skaia OA; Sokolov AA
    Vrach Delo; 1989 Oct; (10):64-7. PubMed ID: 2694612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biochemical mechanisms of mildronate action during ischemic stress].
    Dambrova M; Daĭia D; Liepin'sh E; Kir'ianova O; Kalvin'sh I
    Lik Sprava; 2004 Mar; (2):68-74. PubMed ID: 15208880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The efficacy of the mildronate treatment of patients with ischemic stroke].
    Vinichuk SM
    Vrach Delo; 1991 Jul; (7):77-9. PubMed ID: 1771844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hypoxemia and acid-base equilibrium disorders in chronic cor pulmonale syndrome with circulatory failure].
    Miturzyńska-Stryjecka H; Widomska-Czekajska T
    Pol Tyg Lek; 1973 Aug; 28(34):1308-12. PubMed ID: 4756398
    [No Abstract]   [Full Text] [Related]  

  • 10. Protection of azidothymidine-induced cardiopathology in mice by mildronate, a mitochondria-targeted drug.
    Klusa V; Pupure J; Isajevs S; Rumaks J; Gordjushina V; Kratovska A; Taivans I; Svirskis S; Viksna L; Kalvinsh I
    Basic Clin Pharmacol Toxicol; 2006 Oct; 99(4):323-8. PubMed ID: 17040219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Change of concentration endothelin-1 in rats on a background of alcohol and /or mildronate treatment].
    Sakvarelidze EP; Zakaraia MV; Megreladze TI
    Georgian Med News; 2006 Jun; (135):131-4. PubMed ID: 16905832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in fatty acids content in blood red cells of patients with iron-deficiency anemia treated with sorbifer and mildronate].
    Goncharova EV; Govorin AV
    Ter Arkh; 2008; 80(6):65-8. PubMed ID: 18655480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mildronate effects on oxidant stress in type 2 diabetic patients with diabetic peripheral (sensomotor) neuropathy].
    Statsenko ME; Poletaeva LV; Turkina SV; Apukhtin AF; Dudchenko GP
    Ter Arkh; 2008; 80(10):27-30. PubMed ID: 19105409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of effectiveness of treatment of cochleovestibular disorders with mildronate].
    Luchikhin LA; Pankova TB; Kakymov MI
    Vestn Otorinolaringol; 1991; (2):36-40. PubMed ID: 2048251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mildronate in geriatric patients with cardiac failure].
    Kalvinsh I; Visokinskas A; Bagdonas G; Knasene Iu; Lesaukaite V; Matsiyauskene Iu
    Ter Arkh; 2006; 78(9):75-7. PubMed ID: 17076229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The use of mildronat in heart failure in patients with chronic ischemic heart disease].
    Sakharchuk II; Denisenko GT; Grushko VS; Bodaretskaia OI; Pishchalenko AN
    Vrach Delo; 1989 Sep; (9):21-3. PubMed ID: 2609613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mildronat--treatment of cardio-neurologic pathology in ischemia and hypoxia].
    Afanas'ev VV; Murashko NK
    Lik Sprava; 2012; (7):68-74. PubMed ID: 23350117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic approach in very extreme hypoxemia in chronic cor pulmonale].
    Zamotaev IP; Kabakov AI
    Kardiologiia; 1979 Feb; 19(2):101-2. PubMed ID: 423426
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effect of mildronate on erythrocyte membrane permeability in experimental lung pathology].
    Antonenko LI; Frantsuzova SB; Arshinnikova LL
    Eksp Klin Farmakol; 1992; 55(6):33-5. PubMed ID: 1305872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mildronate: cardioprotective action through carnitine-lowering effect.
    Dambrova M; Liepinsh E; Kalvinsh I
    Trends Cardiovasc Med; 2002 Aug; 12(6):275-9. PubMed ID: 12242052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.